Enclomiphene Citrate for Male Fertility: Evidence, Dosage, and Protocol

Clinical Evidence: Enclomiphene for Male Fertility

The foundational insight behind enclomiphene’s fertility application is that it solves a problem that has long plagued male hormone management: how to restore testosterone without sacrificing sperm production. Testosterone and spermatogenesis are both downstream of the same HPG axis, yet exogenous testosterone replacement destroys spermatogenesis while enclomiphene restores both simultaneously. The Wiehle et al. (2014) Phase III trial made this distinction concrete with controlled, comparative data. Men receiving testosterone gel showed a 25% reduction in sperm concentration over the study period. Men receiving enclomiphene showed a 14% increase in sperm concentration over the same period. The difference between these outcomes, measured head-to-head in the same randomised study, represents the most direct available evidence for why enclomiphene is the preferred option for hypogonadal men who care about fertility. Wiehle et al., 2014, doi:10.1111/andr.12150

Drobnis et al. (2017) extended this evidence with a more detailed analysis of sperm parameters during enclomiphene therapy. The study documented that enclomiphene maintained or improved sperm concentration, total motile sperm count, progressive motility, and morphology across the treatment period. These are the four parameters that fertility specialists use to assess male factor contribution to couple infertility. Maintaining all four while simultaneously raising serum testosterone is an outcome profile that no other oral compound reliably achieves. The mechanism is not complicated: enclomiphene raises LH (which drives intratesticular testosterone production by Leydig cells, providing the paracrine signal essential for sperm maturation) and FSH (which directly stimulates Sertoli cells to support spermatogenesis), while avoiding the peripheral estrogenic effects of zuclomiphene that could potentially impair sperm function at the epididymal level.

The particular clinical population where enclomiphene is most impactful is men recovering from TRT-induced hypogonadism who wish to restore fertility. TRT produces profound HPG axis suppression, with LH and FSH reduced to undetectable levels and intratesticular testosterone collapsing from its physiologic concentration of approximately 100 ng/mL to levels insufficient to support spermatogenesis. After discontinuing TRT, HPG axis recovery can take months to years and is not guaranteed to be complete, particularly in men who have been on TRT for extended periods. Enclomiphene accelerates this recovery by actively stimulating the hypothalamic GnRH pulse generator and driving gonadotropin restoration from the first week of use. The 10-hour half-life of enclomiphene means it is fully cleared overnight and exerts its effect through a clean, isomer-specific mechanism without the confounding zuclomiphene accumulation that complicates racemic clomid use in this context.

For men currently on TRT who are transitioning off in preparation for fertility treatment, the typical protocol involves stopping TRT and beginning enclomiphene 12.5 to 25 mg/day simultaneously. This prevents the period of profound hormonal deficiency that would otherwise occur during HPG axis recovery, maintains quality of life and testosterone levels during the recovery period, and accelerates the timeline to adequate spermatogenesis. Semen analysis at baseline (just before stopping TRT), at 6 weeks, and at 3 months tracks the recovery trajectory. Most men see meaningful sperm count recovery by the 3-month mark, though men with longer TRT histories may require 6 months for full recovery.

Mechanism: How Enclomiphene Supports Spermatogenesis

FSH Stimulation of Sertoli Cells

Sertoli cells are the nurse cells that physically support and biochemically guide developing sperm cells throughout the 74-day spermatogenic cycle. FSH is the primary regulator of Sertoli cell activity. When FSH binds to its receptor on Sertoli cells, it activates a cAMP-dependent signalling cascade that upregulates androgen-binding protein production, transferrin secretion, inhibin B synthesis, and an array of paracrine growth factors including GDNF and SCF that support germ cell self-renewal and differentiation. In men with secondary hypogonadism, FSH is deficient because hypothalamic GnRH stimulation of the pituitary is inadequate. Enclomiphene removes the negative feedback brake on the hypothalamus, increasing GnRH pulsatility, which drives FSH secretion from the anterior pituitary, which restores Sertoli cell activity and spermatogenic output. This is the same FSH-restoration mechanism used by injectable FSH preparations in fertility treatment, achieved orally through hypothalamic pharmacology rather than through direct gonadotropin administration.

Intratesticular Testosterone and Sperm Maturation

Sperm maturation in the later stages of spermatogenesis, particularly the spermiogenesis phase where round spermatids transform into elongated spermatozoa with acrosomes and flagella, is critically dependent on high intratesticular testosterone concentrations. The testosterone concentration within the seminiferous tubule lumen must be approximately 50 to 100 times higher than peripheral serum testosterone to drive the androgen receptor signalling that guides late-stage sperm differentiation. This concentration gradient is maintained by Leydig cell testosterone production and its direct paracrine diffusion into adjacent tubules. LH from the pituitary drives this Leydig cell activity. Enclomiphene raises LH by stimulating hypothalamic GnRH, which restores Leydig cell function and re-establishes the high intratesticular testosterone gradient that sperm maturation requires. This is the mechanistic reason why exogenous testosterone, which suppresses LH and eliminates Leydig cell activity, is contraceptive even when serum testosterone is elevated.

No Estrogenic Impairment of Sperm Function

The pure isomer profile of enclomiphene, free from zuclomiphene’s estrogenic activity, provides a subtle but meaningful fertility advantage. Estrogen receptors are expressed in the epididymis, and estrogen signalling plays a role in sperm maturation and capacitation in the epididymal environment. At physiologic estradiol levels, this is appropriate and necessary. However, the partial agonist activity of zuclomiphene at estrogenic receptors, which accumulates with long-term racemic clomid use, can potentially push estrogen receptor activity in the epididymis beyond the physiologic optimum, impairing sperm function in ways that are not captured by standard semen analysis parameters. Because enclomiphene contains no zuclomiphene and has no estrogenic activity anywhere in the body, the epididymal hormonal environment remains undisturbed by any compound-specific effect. The only change in estrogen signalling is the modest increase in estradiol resulting from aromatisation of the higher testosterone levels produced by enclomiphene treatment, which is the same physiologic aromatisation that occurs during any testosterone-raising intervention and is easily managed by monitoring estradiol levels.

Dosage Protocol for Male Fertility

• Starting dose: 12.5 mg once daily in the morning. Effective for most men with secondary hypogonadism at this dose.
• Escalation: If testosterone and LH/FSH have not risen meaningfully at 4 weeks, increase to 25 mg/day.
• Post-TRT recovery protocol: Begin 12.5 to 25 mg/day simultaneously with TRT discontinuation to prevent the hormonal trough period and accelerate HPG axis recovery.
• Baseline semen analysis: Obtain before starting enclomiphene. Document sperm concentration, total motile count, progressive motility, and morphology. This baseline is the reference for assessing treatment response.
• Baseline bloodwork: Total testosterone, LH, FSH, estradiol. This confirms secondary hypogonadism and provides the pre-treatment hormonal reference.
• Follow-up semen analysis at 90 days: One spermatogenic cycle. This is the first meaningful timepoint to assess sperm parameter improvement.
• Follow-up bloodwork at 4 weeks: Total testosterone, LH, FSH, estradiol. Confirms HPG axis activation and allows dose adjustment.
• Estradiol management: Enclomiphene increases testosterone, which aromatises to estradiol. Monitor estradiol and manage if clinically elevated. Target estradiol below 35 to 40 pg/mL for optimal fertility outcomes.
• Duration: Continue for at least 3 months before fertility assessment. For post-TRT recovery, 3 to 6 months is typically required; longer TRT histories may need up to 12 months for full sperm recovery.
• IVF/ICSI: Continue enclomiphene during ART cycles to maintain the best possible sperm parameters for retrieval or natural conception.

Enclomiphene vs hCG for Fertility After TRT

Frequently Asked Questions

How long does it take to restore sperm count after stopping TRT with enclomiphene?

The timeline for sperm recovery after TRT depends on several factors: duration of TRT use, baseline sperm parameters before TRT, and individual HPG axis responsiveness. For most men who used TRT for less than 2 years, meaningful sperm recovery on enclomiphene begins by the 3-month mark (one spermatogenic cycle) and continues improving through 6 months. Men who used TRT for more than 3 to 5 years may require 6 to 12 months for full recovery, and some may not fully recover without adding injectable FSH to the protocol. The first semen analysis should be performed at exactly 90 days from starting enclomiphene. If sperm concentration is improving but has not yet reached normal ranges, continue enclomiphene for another 90 days and re-check. Progress between the 3-month and 6-month semen analyses is the best predictor of eventual full recovery.

Is enclomiphene safe to use during IVF attempts?

Yes. Enclomiphene does not interact with the gonadotropin-based female stimulation protocols used in IVF. The male partner continues the same enclomiphene protocol throughout the IVF cycle. There is no pharmacological reason to stop enclomiphene before the sperm collection appointment, and doing so would be counterproductive, as ongoing enclomiphene use maintains the elevated FSH and intratesticular testosterone that support optimal sperm quality on the day of retrieval. For ICSI cycles where only a single viable sperm is needed per oocyte, maintaining the best possible sperm morphology is important, and enclomiphene’s sperm-parameter-preserving effects are a clinical advantage even in the ICSI context.

How does enclomiphene compare to hCG for fertility after TRT?

Both compounds work by activating Leydig cells, but through different pathways. hCG directly mimics LH, binding to LH receptors on Leydig cells and stimulating intratesticular testosterone production. This drives one component of spermatogenesis but leaves the FSH pathway unstimulated. For men with severe FSH deficiency, hCG alone may restore intratesticular testosterone without fully restoring Sertoli cell activity, resulting in incomplete spermatogenic recovery. Enclomiphene, by stimulating the hypothalamus to increase GnRH pulsatility, drives increases in both LH and FSH simultaneously. This dual pathway stimulation is more physiologically complete and may produce better sperm count outcomes in men with severe spermatogenic suppression. In practice, many fertility specialists start with enclomiphene due to its oral convenience and cost advantage, reserving the combination of hCG plus injectable FSH for men who do not respond adequately after 6 months of enclomiphene alone.

How to Source Enclomiphene in Canada

Elite Bio Supply provides enclomiphene citrate for research purposes. Researchers investigating the isomer-specific pharmacology of clomiphene in the context of male reproductive function, spermatogenesis, and gonadotropin dynamics will find this compound directly applicable to studies of HPG axis biology and male fertility physiology.

Related Guides

• Enclomiphene Dosage Guide: Protocols by Use Case
• Enclomiphene Side Effects and Safety Profile
• Where to Buy Enclomiphene in Canada
• Enclomiphene for Secondary Hypogonadism
• SERMs for Men: Complete Guide